rs376848284
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002334.4(LRP4):c.2738G>A(p.Gly913Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002334.4 missense
Scores
Clinical Significance
Conservation
Publications
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- congenital myasthenic syndrome 17Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sclerosteosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sclerosteosis 2Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| LRP4 | NM_002334.4 | c.2738G>A | p.Gly913Glu | missense_variant | Exon 20 of 38 | ENST00000378623.6 | NP_002325.2 | |
| LRP4 | XM_017017734.2 | c.2738G>A | p.Gly913Glu | missense_variant | Exon 20 of 39 | XP_016873223.1 | ||
| LRP4 | XM_011520103.3 | c.1934G>A | p.Gly645Glu | missense_variant | Exon 14 of 32 | XP_011518405.1 | ||
| LRP4 | XM_011520104.3 | c.503G>A | p.Gly168Glu | missense_variant | Exon 5 of 23 | XP_011518406.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000329  AC: 5AN: 152172Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000119  AC: 3AN: 251486 AF XY:  0.0000147   show subpopulations 
GnomAD4 exome  AF:  0.0000445  AC: 65AN: 1461684Hom.:  0  Cov.: 32 AF XY:  0.0000385  AC XY: 28AN XY: 727100 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000329  AC: 5AN: 152172Hom.:  0  Cov.: 32 AF XY:  0.0000269  AC XY: 2AN XY: 74356 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17    Uncertain:2 
- -
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LRP4 protein function. ClinVar contains an entry for this variant (Variation ID: 582578). This variant has not been reported in the literature in individuals affected with LRP4-related conditions. This variant is present in population databases (rs376848284, gnomAD 0.005%). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 913 of the LRP4 protein (p.Gly913Glu). -
Inborn genetic diseases    Uncertain:1 
The c.2738G>A (p.G913E) alteration is located in exon 20 (coding exon 20) of the LRP4 gene. This alteration results from a G to A substitution at nucleotide position 2738, causing the glycine (G) at amino acid position 913 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at